Two separate legal tracks now control the future of federal cannabis scheduling, and neither one resolves this year. Today federal agencies face a deadline to respond to a motion in the DEA proceeding, while the court challenge to the April reclassification order has a briefing calendar running into February 2027.
The distinction matters because each track answers a different question. Operators who mix them up will misread their own tax position.
What is today’s October 13 deadline about?
On September 29, the DEA’s chief administrative law judge temporarily stayed the broader rescheduling proceeding after opponents asked to introduce a Government Accountability Office report on weaknesses in federal drug scheduling procedures. Federal agencies had to respond to that request by October 13. The judge will then decide whether to admit the report into the record and allow more briefing. The GAO report flagged gaps in agency procedures. It did not conclude that marijuana should remain in Schedule I, and it did not invalidate the federal government’s marijuana specific evaluation. This is a procedural pause, not a verdict, a point we covered when the judge first hit pause in September.
What is the separate court case deciding?
The D.C. Circuit is reviewing an April 2026 order from then Acting Attorney General Todd Blanche that moved certain marijuana products into Schedule III. The order covers marijuana under qualifying state medical licenses and FDA approved drug products. It is not a blanket reclassification of all cannabis activity. Three challenges were consolidated, brought by groups including Smart Approaches to Marijuana and the attorneys general of Indiana and Nebraska, while the Justice Department defends the order. On October 9 the parties proposed a briefing schedule: opening brief November 24, government response January 13 2027, final briefs February 19, with oral arguments to follow. In September the court declined to suspend the April order during litigation, so the Schedule III treatment stands for the covered categories while the case proceeds. The starting gun framing from last week still holds: the direction is set, the timeline is not.
Why does the distinction matter for operators?
Section 280E of the tax code blocks normal business deductions for companies dealing in Schedule I or II substances. Schedule III treatment can change the federal tax picture in a real way. But the April order has limited scope, so no operator should assume every activity gets the same treatment. The open questions are which activities qualify, whether the order survives judicial review, and how the broader DEA proceeding ends. Those questions sit at the center of the IRS putting cannabis tax guidance on its priority list, and they will stay open well into next year.
What happens next on the calendar?
Watch the judge’s ruling on the GAO report in the DEA case, then the November 24 opening brief in the D.C. Circuit. Neither track produces a final answer this year. For now, operators should separate the benefits available under current rules from bets on future rulings. Plan for the long calendar. Price in the uncertainty.
FAQs
- What is the October 13 deadline?
The date federal agencies had to respond to a motion about admitting a GAO report into the DEA rescheduling record. It is procedural, not a decision on rescheduling itself. - Did the GAO report say marijuana should stay in Schedule I?
No. It found gaps in federal scheduling procedures without judging marijuana’s proper schedule. - What did the April 2026 order do?
It moved certain marijuana products under qualifying state medical licenses and FDA approved products into Schedule III. It was not a blanket reclassification of all cannabis activity. - When will the court case be decided?
Briefing runs into February 2027, with oral arguments after. No ruling date has been set. - How does this affect cannabis taxes?
Section 280E limits deductions for Schedule I and II businesses. Schedule III treatment can improve the tax position for qualifying operations, but the scope is limited and still under review.
Source: IgniteIt: Marijuana Rescheduling Hits a New Deadline Today, With Court Fight Stretching Into 2027.